CoChat

Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition

Open access
Caffa, Irene, D’Agostino, Vito, Damonte, Patrizia, Soncini, Debora, Cea, Michele, Monacelli, Fiammetta, Odetti, Patrizio, Ballestrero, Alberto, Provenzani, Alessandro, Longo, Valter D., Nencioni, Alessio · 2015 · Oncotarget
Cited by 94

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

// Irene Caffa 1 , Vito D’Agostino 2 , Patrizia Damonte 1 , Debora Soncini 1 , Michele Cea 1 , Fiammetta Monacelli 1 , Patrizio Odetti 1,3 , Alberto Ballestrero 1,3 , Alessandro Provenzani 2 , Valter D. Longo 4,5 and Alessio Nencioni 1,3 1 Department of Internal Medicine, University of Genoa, Genoa, Italy 2 Laboratory of Genomic Screening, Centre for Integrative Biology, CIBIO, University of Trento, Trento, Italy 3 IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 4 Longevity Institute, School of Gerontology, Department of Biological Sciences, University of Southern California, Los Angeles, CA, USA 5 IFOM, FIRC Institute of Molecular Oncology, Milan, Italy Correspondence to: Valter D. Longo, email: // Alessio Nencioni, email: // Keywords : tyrosine kinase inhibitors, fasting, MAPK pathway, E2F transcription factors, cell cycle regulation Received : March 04, 2015 Accepted : March 11, 2015 Published : March 30, 2015 Abstract Tyrosine kinase inhibitors (TKIs) are now the mainstay of treatment in many types of cancer. However, their benefit is frequently short-lived, mandating the search for safe potentiation strategies. Cycles of fasting enhance the activity of chemo-radiotherapy in preclinical cancer models and dietary approaches based on fasting are currently explored in clinical trials. Whether combining fasting with TKIs is going to be potentially beneficial remains unknown. Here we report that starvation conditions increase the ability of commonly administered TKIs, including erlotinib, gefitinib, lapatinib, crizotinib and regorafenib, to block cancer cell growth, to inhibit the mitogen-activated protein kinase (MAPK) signaling pathway and to strengthen E2F-dependent transcription inhibition. In cancer xenografts models, both TKIs and cycles of fasting slowed tumor growth, but, when combined, these interventions were significantly more effective than either type of treatment alone. In conclusion, cycles of fasting or of specifically designed fasting-mimicking diets should be evaluated in clinical studies as a means to potentiate the activity of TKIs in clinical use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.3689

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 94

Metadata

Authors
Caffa, I., D’Agostino, V., Damonte, P., Soncini, D., Cea, M., Monacelli, F., Odetti, P., Ballestrero, A., Provenzani, A., Longo, V. D., & Nencioni, A.
Venue
Oncotarget
Published
2015-03-18
Volume
6
Issue
14
Pages
11820-11832
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1560626964
Cited by
94
References
2
FWCI
4.73
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.